Nortrel Kit
Product Images NDC 0555-9010
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Nortrel (NDC 0555-9010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Nortrel® 0.5/35 (norethindrone And Ethinyl Estradiol Tablets Usp) 28 Day Regimen, 3 Blister Cards, 28 Tablets Each Carton, Part 1 Of 2 (Image 10)
This is a description of Nortrel®, a brand of oral contraceptive pills containing norethindrone and ethinyl estradiol tablets. The pills come in blister cards and each card contains 28 tablets. The usual dosage is one tablet daily as recommended in the enclosed detailed product information. The medication should be stored at room temperature between 20°C to 25°C. This medication should be kept out of the reach of children. The carton contains one combination labeling piece of information intended for the patient, and informational pieces are to be provided to the patient with each prescription. The manufacturer is Teva Pharmaceuticals USA, Inc.*
Nortrel® 0.5/35 (norethindrone And Ethinyl Estradiol Tablets Usp) 28 Day Regimen, 3 Blister Cards, 28 Tablets Each Carton, Part 2 Of 2 (Image 11)
This appears to be a partial advertisement or label for a birth control product called "norethindrone and ethinyl estradiol tablets USP" with a strength of 0.5/35. The text mentions that the product is intended to be taken orally and used as a contraceptive to prevent pregnancy. There is also a mention of a "B only" status, although it is unclear what this signifies. The last line of text seems to be unrelated and may be a error.*
Image 12
Image 2
Image 3
Image 4
This text appears to be a list of several studies with their respective dates, acronyms, and focus on contraceptive use among women. The text also includes some numerical values and estimates denoted by OR/RR, and some unreadable characters. It is unclear what the values and estimates represent without more context.*
Image 5
Image 6
Image 7
This is an output of a drug label. The drug is likely a contraceptive containing the active ingredients norethindrone and ethinyl estradiol tablets. The label suggests that the drug is intended to prevent pregnancy and is not effective against sexually transmitted diseases. It is available in packs of 21 tablets, and the brand name appears to be "Cortans 3 bl e." The label also mentions "TEUA WOMEN'S HeaLTH®" which could be the manufacturer's brand.*
Image 8
Image 9
This is a description of Norrel®, which is an oral contraceptive intended to prevent pregnancy. It contains six blister cards, each with 28 tablets, 21 yellow tablets containing 1mg_norethindrone USP and 0.035mg ethinyl estradiol USP, and seven white inert tablets. The product does not protect against HIV infection (AIDS) and other sexually transmitted diseases. The rest of the text seems to include other details such as product numbers, manufacturer information, and graphic design instructions.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.